Our Services
Medical Information
Helpful Resources
Published on: 9/14/2026
Most Cymbalta (duloxetine) side effects such as nausea, dizziness, drowsiness, dry mouth, and constipation appear in the first one to two weeks and ease within two to four weeks as the body adjusts, though women over 65 often need longer because slower liver and kidney clearance keeps the drug in the system, and effects like sedation, low sodium, fall risk, or bone loss may persist for as long as the medication is taken. Discontinuation symptoms after stopping typically last one to two weeks, but can extend for several weeks when the dose is reduced too quickly. Duration also depends on dose, how long the drug has been used, and interactions with other prescriptions, which are common in this age group, so there are several important factors to consider below before assuming a symptom is temporary. Because persistent dizziness, confusion, unusual bruising, or worsening mood in older women can signal a serious reaction rather than normal adjustment, timing matters when deciding whether to wait or call a clinician. Take a free, instant, online symptom check to clarify whether what you are feeling fits an expected adjustment period or warrants prompt medical review, and get clear guidance on your next steps.
Last reviewed for medical accuracy: 09/13/2026
Cymbalta (duloxetine) is a commonly prescribed antidepressant and nerve-pain medication. In women over 65, age-related changes in metabolism and body composition can affect how long side effects last and how intense they feel. Below is an overview of what you might expect, practical tips to ease discomfort, and when to seek help.
As we age, our bodies process drugs differently:
All of these factors can stretch out both the onset and duration of side effects.
Every person is different, but most women over 65 see a pattern like this:
First 1–2 weeks (acute phase)
Weeks 2–6 (subacute phase)
After 6–8 weeks (chronic phase)
In many older women, most side effects will significantly diminish by the end of the second month. However, individual factors—like other medications, overall health, and dosage—can extend this period.
| Side Effect | Typical Onset | Expected Duration |
|---|---|---|
| Nausea | Within hours | 1–3 weeks, often fading by week 4 |
| Dry mouth | First few days | 2–6 weeks |
| Headache | First week | 2–4 weeks |
| Drowsiness/fatigue | First dose | 2–8 weeks |
| Insomnia | 1–2 days | 2–6 weeks |
| Dizziness | First week | 1–4 weeks |
| Constipation | First week | 2–6 weeks |
If side effects continue beyond 8 weeks or seriously interfere with daily life, talk to your doctor about adjusting your dose or switching medications.
Stopping Cymbalta abruptly can cause withdrawal-like effects, sometimes called “discontinuation syndrome.” Older women can be more vulnerable. Symptoms may include:
These usually appear within 1–3 days of missing a dose and often last 1–3 weeks. A slow taper—reducing your dose over several weeks—can help minimize these symptoms.
While most side effects are mild and temporary, some require prompt medical attention:
For any potentially life-threatening or serious issues, always call your doctor or head to the nearest emergency department.
If you’re unsure whether what you’re feeling is related to Cymbalta, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to get personalized guidance and decide if you need professional care.
Medicine affects everyone differently. If you’re ever in doubt—especially about something serious—please speak to a doctor.
(References)
* Drugs for depression. Med Lett Drugs Ther. 2023 Dec 11;65(1691):193-200. doi: 10.58347/tml.2023.1691a. PMID: 38133585.
* Drugs for migraine. Med Lett Drugs Ther. 2023 Jun 12;65(1678):89-96. doi: 10.58347/tml.2023.1678a. PMID: 37266987.
* Drugs for Depression. Med Lett Drugs Ther. 2020 Feb 24;62(1592):25-32. PMID: 32320387.
* Buoli M, Serati M, Cahn W. Alternative pharmacological strategies for adult ADHD treatment: a systematic review. Expert Rev Neurother. 2016;16(2):131-44. doi: 10.1586/14737175.2016.1135735. 2016 Jan 14. PMID: 26693882.
* Bragg S, Marrison ST, Haley S. Diabetic Peripheral Neuropathy: Prevention and Treatment. Am Fam Physician. 2024 Mar;109(3):226-232. PMID: 38574212.
* Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014 Jan 3;2014(1):CD007115. doi: 10.1002/14651858.CD007115.pub3. 2014 Jan 3. PMID: 24385423; PMCID: PMC10711341.
* Boehmerle W, Huehnchen P, Endres M. [Chemotherapy-induced neuropathy]. Nervenarzt. 2015 Feb;86(2):156-60. doi: 10.1007/s00115-014-4126-3. PMID: 25586233.
* Zhang Z, Yao L. Drug risks associated with sarcopenia: a real-world and GWAS study. BMC Pharmacol Toxicol. 2024 Nov 7;25(1):84. doi: 10.1186/s40360-024-00813-y. 2024 Nov 7. PMID: 39511635; PMCID: PMC11542392.
* Shelton RC. Serotonin and Norepinephrine Reuptake Inhibitors. Handb Exp Pharmacol. 2019;250:145-180. doi: 10.1007/164_2018_164. PMID: 30838456.
* Kaufman KR, Podolsky D, Greenman D, Madraswala R. Antidepressant-selective gynecomastia. Ann Pharmacother. 2013 Jan;47(1):e6. doi: 10.1345/aph.1R491. 2013 Jan 16. PMID: 23324513.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.